Prostate Stem Cell Antigen (PSCA) (C-Term) Peptide
Aperçu rapide pour Prostate Stem Cell Antigen (PSCA) (C-Term) Peptide (ABIN8109098)
Antigène
Origine
Source
Application
-
-
Protein Region
- C-Term
-
Fonction
- PSCA Peptide - C-terminal region
-
Séquence
- TVISKGCSLN CVDDSQDYYV GKKNITCCDT DLCNASGAHA LQPAAAILAL
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-PSCA Antibody(ARP42250_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PSCA (Prostate Stem Cell Antigen (PSCA))
-
Sujet
-
Background Information: This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals, this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants.
Alternative Symbols: PRO232
-
Poids moléculaire
- 8kDa
-
ID gène
- 8000
-
NCBI Accession
- NP_005663
-
UniProt
- O43653
Antigène
-